Partner Headlines - ICPT

  1. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  2. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  3. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  4. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  5. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  6. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  7. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  8. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  9. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  10. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  11. Morning Market Losers

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Meet The 5 Companies Loving Obamacare

    Benzinga
  14. Morning Market Losers

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. Benzinga's Top Initiations

    Benzinga
  17. Cowen Initiates Intercept At Outperform

    Benzinga
  18. Four biotech takeover targets?

    IBD
  19. 4 Biotechs That Might Be Bought Soon

    IBD
  20. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  21. Morning Market Losers

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. CNBC's Stock Pops & Drops From August 12

    Benzinga
  24. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  25. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  26. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  27. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  28. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  29. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  30. Benzinga's Volume Movers

    Benzinga
  31. Morning Market Movers

    Benzinga
  32. Conatus Shares Move Higher On Industry Data

    Benzinga
  33. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  34. Benzinga's Top #PreMarket Gainers

    Benzinga
  35. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  36. INTERCEPT PHARMACEUTICALS

    IBD
  37. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  38. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  39. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  40. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  41. Benzinga's Top Initiations

    Benzinga
  42. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  43. Top Healthcare Movers For June 9, 2014

    Benzinga
  44. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  45. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  46. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  47. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  48. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  49. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  50. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  51. Top Trending Tickers On StockTwits For March 17

    Benzinga
  52. Benzinga's Top #PreMarket Losers

    Benzinga
  53. Morning Gainers for Friday, March 14, 2014

    Benzinga
  54. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  55. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  56. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  57. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  58. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  59. Mid-Morning Market Update: Markets Rise; Bank of America Profit ...

    Benzinga
  60. Benzinga's Top #PreMarket Gainers

    Benzinga
  61. Market Wrap For January 14: Markets Rebound On Earnings Season ...

    Benzinga
  62. Mid-Afternoon Market Update: Markets Continue Rally as Tesla ...

    Benzinga
  63. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  64. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  65. Morning Market Losers

    Benzinga
  66. Benzinga's Top #PreMarket Losers

    Benzinga
  67. Intercept Reports Additional Details About FLINT Clinical Trial ...

    Benzinga
  68. Intercept to Present at the JP Morgan Healthcare Conference on ...

    Benzinga
  69. Market Wrap For January 10: Job Growth Weak, But Unemployment ...

    Benzinga
  70. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing ...

    Benzinga
  71. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; ...

    Benzinga
  72. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  73. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss ...

    Benzinga
  74. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  75. Benzinga's Volume Movers

    Benzinga
  76. Stocks Hitting 52-Week Highs

    Benzinga
  77. Citi Maintains on Intercept Pharmaceuticals

    Benzinga
  78. Stock Futures Trim Early Gains; Oriental Education Leads IBD ...

    IBD
  79. Benzinga's Top #PreMarket Gainers

    Benzinga
  80. Intercept drug hits endpoint

    IBD
  81. Mid-Afternoon Market Update: Markets Moving Sideways Ahead of ...

    Benzinga
  82. Mid-Day Market Update: U.S. Stocks Turn Red; Bed Bath & Beyond ...

    Benzinga
  83. Intercept Pharma Liver-Disease Drug Scores In Trial

    IBD
  84. Benzinga's Volume Movers

    Benzinga
  85. Morning Market Movers

    Benzinga
  86. Benzinga's Top #PreMarket Gainers

    Benzinga
  87. Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's ...

    Benzinga
  88. Intercept Prices 1.5M Share Offering at $62.50/Share

    Benzinga
  89. UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals ...

    Benzinga
  90. UPDATE: Wedbush Raises PT on Intercept Pharmaceuticals Following ...

    Benzinga
  91. Intercept Pharma Begins Phase 2 NASH Trial of OCA in Japan

    Benzinga
  92. Intercept Pharmaceuticals Completes Enrollment in Phase 3 Primary ...

    Benzinga
  93. UPDATE: BMO Capital Markets Initiates Intercept Pharmaceuticals ...

    Benzinga
  94. Stocks Hitting 52-Week Lows

    Benzinga
  95. Four IPOs Burst Out The Gate

    IBD
  96. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
  97. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
Trading Center